In an autochthonous model of pancreatic cancer, we have previously shown that loss of PEDF results in accelerated mutant KRAS-induced pancreatic tumorigenesis, concomitant with metastatic disease [42]. Here, SERPINF1 is linked to pancreatic neoplasm.